Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Terlipressin Infusion vs Bolus for Variceal Hemorrhage
NCT04028505Phase 3Unknown
- Sponsor
- Aga Khan University
- Start
- Oct 2018
- Primary completion
- Apr 2020
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of terlipressin in Gastroesophageal Variceal Hemorrhage, sponsored by Aga Khan University. Primary endpoints: Reduction in tachycardia at 6 weeks and Mean Arterial Pressure at 6 weeks. Status: unknown.
02
Drugs
terlipressin
03
Conditions
Gastroesophageal Variceal Hemorrhage
Beyond the preview
Go deeper on NCT04028505.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04028505.